News and Trends 11 Aug 2020How European Startups Have Advanced Cancer T-Cell Therapy in 2020 With the help of a huge €66M Series A round last week, the German startup T-knife is developing cancer T-cell… August 11, 2020 - 8 minutesmins - By Kostas Vavitsas Share WhatsApp Twitter Linkedin Email
Best in Biotech 4 Nov 2019Top 10 Biotech Companies Leaving a Mark in Munich These are the top 10 biotech companies in Munich, one of the hottest hubs for the biotechnology industry. One of… November 4, 2019 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 14 May 2018German Biotech Expands Oncology Deal with Bluebird bio to $1.5Bn Medigene and bluebird bio are increasing the number of cancer targets against which to develop TCR candidates, raising their already huge… May 14, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 Mar 2018Say Hello to the Top 14 Entrepreneurial Women in European Biotech Today, March 8, is international women's day. To celebrate the achievements of women we're revisiting our list of the women… March 8, 2018 - 8 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Startup Scout 2 Jun 2017This French Biotech Wants to Reinvent DC-based Immunotherapies This week we had the chance to visit both Grenoble and Liège, where the French-Belgian biotech hybrid PDC*line Pharma has… June 2, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Interview 20 Apr 2017Which EU Immuno-Oncology Company are you Cheering for? Immuno-oncology represents a huge breakthrough towards the search for a cancer cure. Biotechs all around Europe are developing innovative ways… April 20, 2017 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Infographics 13 Feb 2017Infographic: What’s in Europe’s Immuno-oncology Pipeline? While some might accuse the field of being over-hyped, immuno-oncology continues to attract attention and investment for its potential to cure cancer.… February 13, 2017 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 26 Dec 2016The Largest Deals, Fundraising and Exits of 2016 in European Biotech Curious about which technologies have attracted the most cash in biotech finance this year? Here's a list of the most impressive cash… December 26, 2016 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 25 Nov 2016Stories We Didn’t Cover: Malaria Vaccine Money, Diabetes FDA Approvals Try as we might, we can't cover all the biotech news out there. During the week, we only pick the… November 25, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 29 Sep 2016Titans in Gene Therapy and TCRs make a Massive Deal Medigene has licensed a few candidates from its TCR platform to one of the Boston 'it' biotechs in a deal… September 29, 2016 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jun 2016Key German Hospital to start a Phase I trial in TCR Cell Therapy Medigene will make its clinical debut in TCR, in a collaboration with the Max Delbrück Centre and the Charité Hospital… June 30, 2016 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Jun 201611 Biotech Leaders you should meet in Munich I guess you've read some of our tops lately (VCs, Paris, Unicorns). Those were mainly about specific companies or regions.… June 22, 2016 - 5 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 21 Dec 2015Here’s my Chat with the CBO of Immunocore, the Only EU Biotech to have ever raised €300M in one Round Last Thursday at Genesis in London, I had the chance to meet with Eva-Lotta Allan, CBO of Immunocore (and previously from… December 21, 2015 - 5 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 3 Nov 2015Exclusive from BIO-Europe 2015: Interview of Peter Llewellyn-Davies, CFO at Medigene, Munich-based Immunotherapy Biotech This is the third interview we publish from BIO (yes, we are working hard). It comes after the interview of Simon… November 3, 2015 - 1 minutemin - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jul 2015Adaptimmune’s TCR Therapy Proves its Superiority over its Immuno-oncology Competitors Adaptimmune Therapeutics, an oxford-based company focusing on the use of T-cell therapies to treat cancer, announced today that data from its… July 22, 2015 - 3 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email